Company Overview of Cellectis Plant Sciences Inc
Cellectis Plant Sciences Inc operates as a subsidiary of Cellectis.
1000 Westgate Drive
St Paul, MN 55114
Key Executives for Cellectis Plant Sciences Inc
Compensation as of Fiscal Year 2014.
Cellectis Plant Sciences Inc Key Developments
Cellectis Plant Sciences and Bayer CropScience Extend Partnership to Improve Crops by Gene Editing
Jan 30 14
Cellectis plant sciences has signed two new agreements with Bayer CropScience on gene editing in plants. The agreements extend the companies' existing partnership to introduce targeted modifications to selected plant genes and genomes. The first aim of this extended partnership is to collaboratively create commercial traits for the canola seed market using new technologies developed by Cellectis plant sciences. The second aim is to provide Bayer with access to technologies that enable the directed engineering of plant genomes, such as gene stacking and targeted mutagenesis, for the development of improved crops.
Medicago and Cellectis Successfully Achieve First Step in Research Collaboration
Oct 4 12
Medicago Inc. and Cellectis Plant Sciences Inc, announced the successful completion of the first step in their research collaboration to improve therapeutic proteins produced in tobacco plants. As part of an ongoing effort in the development biosimilar protein therapeutics from tobacco plants, Medicago is partnering with Cellectis to modify the glycosylation of biosimilar product candidates. A biosimilar product is a therapeutic protein, which is similar in terms of quality, safety and efficacy to an already approved and marketed biotherapeutic product. Glycosylation is the addition of sugar molecules to proteins. Modifying the glycosylation of a protein can optimize the efficacy and other characteristics such as solubility, therapeutic half-life, and tissue distribution. Cellectis develops enzymes called nucleases that can specifically cut DNA and modify genes, and can enable the modification of protein glycosylation patterns. These nucleases can enable the development of modified tobacco plants with the goal of producing biosimilar products with optimal efficacy.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries